Shanghai - Delayed Quote CNY

Shandong Weigao Orthopaedic Device Co., Ltd (688161.SS)

Compare
26.01
+0.25
+(0.97%)
At close: December 27 at 3:00:02 PM GMT+8
Loading Chart for 688161.SS
DELL
  • Previous Close 25.76
  • Open 25.90
  • Bid 26.01 x --
  • Ask 26.03 x --
  • Day's Range 25.62 - 26.23
  • 52 Week Range 18.54 - 41.52
  • Volume 658,897
  • Avg. Volume 1,444,088
  • Market Cap (intraday) 10.404B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 68.45
  • EPS (TTM) 0.38
  • Earnings Date --
  • Forward Dividend & Yield 0.24 (0.91%)
  • Ex-Dividend Date Dec 12, 2024
  • 1y Target Est --

Shandong Weigao Orthopaedic Device Co., Ltd. operates as a medical device and pharmaceutical company. The company offers general consumables, such as clinical care consumables and supplies, infection protection supplies, infusion consumables, indwelling needle, anesthesia respiratory consumables, other operating room consumables, and other clinical consumables; endocrine consumables; medical informationization solutions; and orthopedics products, including spine, joint, trauma, sports medicine, orthopedics devices, bone repair materials, and spinal endoscopy products. It also provides oral treatment equipment and dental implant consumables; platelet-rich plasma therapy and negative pressure drainage consumables; and blood purification products comprising hemodialysis equipment and consumables, peritoneal dialysis preparations, and hemodialysis equipment pipeline cleaning products. In addition, the company offers pharmaceutical packaging materials, such as prefilled drug delivery system, medical packaging supplies, and automatic drug delivery system; surgical products, including surgical instruments, dressing supplies, and stoma supplies, as well as electrosurgery consumables, suture supplies, and others. Further, it provides surgical robot; whole blood collection; intervention; in vitro diagnostics; assisted reproduction; medical equipment; rehabilitation series; endoscope; and drugs, comprising injectable products, nephrology drugs, OTC drugs, and other medicines. The company was founded in 1988 and is based in Weihai, China. Shandong Weigao Orthopaedic Device Co., Ltd. operates as a subsidiary of Shandong Weigao Group Medical Polymer Co., Limited.

www.weigaoholding.com/group_list/61.html

2,210

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688161.SS

View More

Performance Overview: 688161.SS

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

688161.SS
36.58%
SSE Composite Index
14.29%

1-Year Return

688161.SS
32.59%
SSE Composite Index
17.29%

3-Year Return

688161.SS
57.17%
SSE Composite Index
6.02%

5-Year Return

688161.SS
78.14%
SSE Composite Index
13.06%

Compare To: 688161.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688161.SS

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    10.40B

  • Enterprise Value

    8.41B

  • Trailing P/E

    68.45

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.23

  • Price/Book (mrq)

    2.66

  • Enterprise Value/Revenue

    6.55

  • Enterprise Value/EBITDA

    44.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.04%

  • Return on Assets (ttm)

    1.22%

  • Return on Equity (ttm)

    4.06%

  • Revenue (ttm)

    1.28B

  • Net Income Avi to Common (ttm)

    154.6M

  • Diluted EPS (ttm)

    0.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2B

  • Total Debt/Equity (mrq)

    0.17%

  • Levered Free Cash Flow (ttm)

    268.69M

Research Analysis: 688161.SS

View More

People Also Watch